<DOC>
	<DOCNO>NCT02181088</DOCNO>
	<brief_summary>The purpose study assess two new malaria vaccine , ChAd63 RH5 MVA RH5 , different dos alone combination . The study enable u assess safety vaccine extent immune response healthy volunteer . We give volunteer one two vaccination , blood test collect information symptom occur vaccination . This first trial use vaccine human .</brief_summary>
	<brief_title>A Phase Ia Clinical Trial Assess Safety Immunogenicity New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone With MVA RH5</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<criteria>Healthy adult age 18 50 year Able willing ( Investigator 's opinion ) comply study requirement Willing allow investigator discuss volunteer 's medical history General Practitioner For female , willingness practice continuous effective contraception study negative pregnancy test day ( ) screen vaccination Agreement refrain blood donation course study Provide write informed consent Participation another research study involve receipt investigational product 30 day precede enrolment , plan use study period Prior receipt investigational malaria vaccine investigational vaccine likely impact interpretation trial data . Administration immunoglobulins and/or blood product within three month precede plan administration vaccine candidate Any confirm suspected immunosuppressive immunodeficient state , include human immunodeficiency virus ( HIV ) infection ; asplenia ; recurrent , severe infection chronic ( 14 day ) immunosuppressant medication within past 6 month ( inhaled topical steroid allow ) History allergic disease reaction likely exacerbate component vaccine , e.g . egg product . Any history anaphylaxis reaction vaccination Pregnancy , lactation willingness/intention become pregnant study History cancer ( except basal cell carcinoma skin cervical carcinoma situ ) History serious psychiatric condition Any serious chronic illness require hospital specialist supervision Suspected known current alcohol abuse define alcohol intake great 42 unit every week Suspected known inject drug abuse 5 year precede enrolment Seropositive hepatitis B surface antigen ( HBsAg ) Seropositive hepatitis C virus ( antibody HCV ) History clinical malaria ( specie ) Travel malaria endemic region study period within previous six month Any clinically significant abnormal find screen biochemistry haematology blood test urinalysis Any significant disease , disorder finding may significantly increase risk volunteer participation study , affect ability volunteer participate study impair interpretation study data Inability study team contact volunteer 's general practitioner ( GP ) confirm medical history safety participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Plasmodium falciparum</keyword>
	<keyword>RH5</keyword>
</DOC>